139 related articles for article (PubMed ID: 4678862)
1. [Thyroid acropachy with an abnormally high concentration of long acting thyroid stimulator].
Momotani N; Suzuki T; Harada S; Nishikawa Y; Ito K
Horumon To Rinsho; 1972 Aug; 20(8):649-53. PubMed ID: 4678862
[No Abstract] [Full Text] [Related]
2. LATS activity, hyperthyroidism, exophthalmos, pretibial myxoedema and acropachy.
Bartholomew C
Br J Clin Pract; 1972 Sep; 26(9):431-3. PubMed ID: 5080337
[No Abstract] [Full Text] [Related]
3. [Significance of long-acting thyroid stimulator. Reflections on the 1st series of results].
Tourneur R; Letonturier P; Sénécal P
Minerva Med; 1974 Mar; 65(19):995-8. PubMed ID: 4406464
[No Abstract] [Full Text] [Related]
4. [The effect of immunosuppressive therapy on the long acting thyroid stimulator (LATS) and the clinical picture in patients with localized myxedema and exophthalmus].
Depisch D; Höfer R; Schatz H
Wien Klin Wochenschr; 1969 Jan; 81(1):8-10. PubMed ID: 5818436
[No Abstract] [Full Text] [Related]
5. [The long acting thyroid stimulator (LATS) in some thyroid diseases. Preliminary results].
Busnardo B; Accordi F; Debiasi S
Acta Isot (Padova); 1968 Oct; 8(2):165-79. PubMed ID: 5761578
[No Abstract] [Full Text] [Related]
6. [The determination of long-acting thyroid stimulator (LATS) in thyroid diseases].
Depisch D; Höfer R; Schatz H
Wien Z Inn Med; 1968; 49(4):121-30. PubMed ID: 5757238
[No Abstract] [Full Text] [Related]
7. [Immunopathogenetic, endocrinologic and therapeutic problems of EMO syndrome. Observations based on a case report].
Göring HD; Ziemer A
Dermatol Monatsschr; 1989; 175(8):492-8. PubMed ID: 2792490
[TBL] [Abstract][Full Text] [Related]
8. Proceedings: Pretibial myxoedema and thyroid acropachy. Possible dermatitis herpetiformis.
Goldin D
Proc R Soc Med; 1973 Oct; 66(10):983-4. PubMed ID: 4800801
[No Abstract] [Full Text] [Related]
9. Serum long acting thyroid stimulator (LATS) and LATS-protector (LATS-P) in Graves' disease associated with localized myxedema.
Hardisty CA; Fowles A; Munro DS
J Endocrinol Invest; 1984 Apr; 7(2):151-5. PubMed ID: 6547156
[TBL] [Abstract][Full Text] [Related]
10. Thyroid acropachy.
Moule B; Grant MC; Boyle IT; May H
Clin Radiol; 1970 Jul; 21(3):329-33. PubMed ID: 5464800
[No Abstract] [Full Text] [Related]
11. The long-acting thyroid stimulator.
Kriss JP
Calif Med; 1968 Sep; 109(3):202-13. PubMed ID: 4235081
[No Abstract] [Full Text] [Related]
12. Proceedings: Studies on long-acting thyroid stimulator protector in serum containing long-acting thyroid stimulator.
Dirmikis S; Munro DS
J Endocrinol; 1975 Mar; 64(3):29P-30P. PubMed ID: 1173370
[No Abstract] [Full Text] [Related]
13. [Hyperthyroidism and the "long acting thyroid stimulator" (LATS)].
Studer H
Schweiz Med Wochenschr; 1967 May; 97(19):622-3. PubMed ID: 5632362
[No Abstract] [Full Text] [Related]
14. [Long-acting thyroid stimulator].
Titov VN
Klin Med (Mosk); 1969 Oct; 47(10):31-9. PubMed ID: 4915396
[No Abstract] [Full Text] [Related]
15. Thyroid acropachy. Case report and literature review.
Winkler A; Wilson D
Mo Med; 1985 Dec; 82(12):756-61. PubMed ID: 3911049
[No Abstract] [Full Text] [Related]
16. Correlation of long-acting thyroid stimulator with serum levels of tri-iodothyronine, thyroxine and thyrotropin in Graves' disease.
Sawhney RC; Kannan V; Rastogi GK
J Assoc Physicians India; 1975 Feb; 23(2):111-4. PubMed ID: 1242389
[No Abstract] [Full Text] [Related]
17. Thyroid suppressibility and long-acting thyroid stimulator in thyrotoxicosis.
Silverstein GE; Burke G
Arch Intern Med; 1970 Oct; 126(4):615-20. PubMed ID: 4097002
[No Abstract] [Full Text] [Related]
18. [Thyrogenic acropachy with spontaneous regression].
Gossmann HH; Hillger H
Rofo; 1990 Jun; 152(6):734-5. PubMed ID: 2163086
[No Abstract] [Full Text] [Related]
19. [Standardization of the radiobiological method for determination of long-acting thyroid stimulator (LATS) in human serum].
Muramoto E; Nicolau W; Ikeda E; de Assis LM; Pieroni RR
AMB Rev Assoc Med Bras; 1972 Oct; 18(10):379-88. PubMed ID: 4539360
[No Abstract] [Full Text] [Related]
20. The clinical significance of plasma thyroid-stimulating ctivity in hyperthyroidism.
Hoffmann MJ; Hetzel BS
Australas Ann Med; 1966 Aug; 15(3):204-9. PubMed ID: 4169740
[No Abstract] [Full Text] [Related]
[Next] [New Search]
